Profil
Paul F.
Engler is the founder of Cactus Feeders, Inc. which was founded in 1975, where he holds the title of Chairman.
Currently, he is a Director at Toragen, Inc. since 2022.
In the past, he worked as a Director at GlobeSecNine, Inc.
Aktiva positioner av Paul F. Engler
| Företag | Position | Start |
|---|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Grundare | 1975-01-01 |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Direktör/Styrelseledamot | 2022-08-15 |
Tidigare kända positioner av Paul F. Engler
| Företag | Position | Slut |
|---|---|---|
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Process Industries |
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Finance |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Health Technology |
















